Trials / Completed
CompletedNCT01535443
Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.
Fase 1 Study to Evaluate the Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Laboratorios Sophia S.A de C.V. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Study to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.
Detailed description
A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac | Drug: Bromfenac Other names: PRO-155 |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2012-02-17
- Last updated
- 2019-10-16
- Results posted
- 2019-07-19
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01535443. Inclusion in this directory is not an endorsement.